Fremanezumab (Anti-CALCA / CGRP)
Fremanezumab (Anti-CALCA / CGRP) (A2791-GRP)
Products
Description
Fremanezumab (Anti-CALCA / CGRP) is a humanized IgG2a monoclonal antibody that selectively and potently targets calcitonin gene-related peptide (CGRP). Fremanezumab has the potential for chronic migraine research.. MW: 145.5 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2791 |
| Target | CGRP Receptor |